Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
38
datasets available to search
ShareScore release 0.7.1
Dataset results
38 results for “mirikizumab”
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
ClinicalTrials.gov study NCT03926130. IPD Sharing: YES. Countries: 34. Publications: 7.
A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy Participants
ClinicalTrials.gov study NCT05069896. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Compare Two Different Formulations of Mirikizumab in Healthy Participants
ClinicalTrials.gov study NCT04548219. IPD Sharing: NO. Countries: 1. Publications: 1.
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
ClinicalTrials.gov study NCT03518086. IPD Sharing: YES. Countries: 35. Publications: 9.
Mirikizumab Real World Protocol
ClinicalTrials.gov study NCT06696014. IPD Sharing: YES. Countries: 2. Publications: 16.
A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)
ClinicalTrials.gov study NCT04004611. IPD Sharing: YES. Countries: 5. Publications: 1.
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
ClinicalTrials.gov study NCT03535194. IPD Sharing: YES. Countries: 16. Publications: 1.
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
ClinicalTrials.gov study NCT04232553. IPD Sharing: YES. Countries: 32. Publications: 0.
A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants
ClinicalTrials.gov study NCT05644353. IPD Sharing: NO. Countries: 1. Publications: 1.
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
ClinicalTrials.gov study NCT06864403. IPD Sharing: YES. Countries: 1. Publications: 61.
A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02589665. IPD Sharing: YES. Countries: 16. Publications: 6.
A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03482011. IPD Sharing: YES. Countries: 9. Publications: 1.
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT03524092. IPD Sharing: YES. Countries: 34. Publications: 10.
A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease
ClinicalTrials.gov study NCT02891226. IPD Sharing: YES. Countries: 14. Publications: 2.
A Study of Mirikizumab in Healthy Participants
ClinicalTrials.gov study NCT04607733. IPD Sharing: NO. Countries: 1. Publications: 1.
A Bioequivalence Study of Citrate Free Mirikizumab (LY3074828) in Healthy Participants
ClinicalTrials.gov study NCT06475729. IPD Sharing: NO. Countries: 1. Publications: 1.
A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants
ClinicalTrials.gov study NCT05515601. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT05767021. IPD Sharing: YES. Countries: 10. Publications: 0.
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
ClinicalTrials.gov study NCT03519945. IPD Sharing: YES. Countries: 36. Publications: 2.
A Safety Study of Mirikizumab (LY3074828)
ClinicalTrials.gov study NCT01947933. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.